Linked EMR + Claims Data for Stronger HEOR Evidence

Manufacturers know that evidence is currency in payer negotiations. Fragmented datasets only tell a partial story that leaves payers skeptical. That’s why linked datasets have become the gold standard for health economics and outcomes research (HEOR). EMRClaims+ from...

Why Flexibility Matters in Pharma Support Programs

Pharma manufacturers can no longer rely on rigid, one-size-fits-all support programs. Yet, many pharma manufacturers struggle to adapt, leading to delays, inefficiencies, and gaps in patient access. Some lose control by fully outsourcing their programs, while others...

Is your PSP Program Future-Ready? 

Over the past two years, I’ve had the privilege of speaking with dozens of manufacturers, payers, and patient advocates about the state of patient access. One truth keeps surfacing: Patient Support Programs are falling behind the moment. They were built in a different...